Korea Investment Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36.1M | Buy |
110,855
+5,096
| +5% | +$1.66M | 0.08% | 240 |
|
2025
Q1 | $28.6M | Buy |
105,759
+12,156
| +13% | +$3.28M | 0.07% | 276 |
|
2024
Q4 | $22M | Sell |
93,603
-14,290
| -13% | -$3.36M | 0.05% | 332 |
|
2024
Q3 | $29.7M | Sell |
107,893
-4,490
| -4% | -$1.23M | 0.07% | 274 |
|
2024
Q2 | $27.3M | Buy |
112,383
+73,220
| +187% | +$17.8M | 0.07% | 268 |
|
2024
Q1 | $5.85M | Buy |
39,163
+6,067
| +18% | +$907K | 0.01% | 552 |
|
2023
Q4 | $6.33M | Buy |
33,096
+35
| +0.1% | +$6.7K | 0.02% | 536 |
|
2023
Q3 | $5.86M | Sell |
33,061
-5,854
| -15% | -$1.04M | 0.02% | 481 |
|
2023
Q2 | $7.39M | Buy |
38,915
+1,656
| +4% | +$315K | 0.02% | 441 |
|
2023
Q1 | $7.46M | Buy |
37,259
+1,116
| +3% | +$224K | 0.02% | 458 |
|
2022
Q4 | $8.59M | Sell |
36,143
-20,987
| -37% | -$4.99M | 0.03% | 455 |
|
2022
Q3 | $11.4M | Buy |
57,130
+1,921
| +3% | +$385K | 0.04% | 397 |
|
2022
Q2 | $8.05M | Sell |
55,209
-6,414
| -10% | -$935K | 0.02% | 468 |
|
2022
Q1 | $10.1M | Sell |
61,623
-1,439
| -2% | -$235K | 0.02% | 442 |
|
2021
Q4 | $10.7M | Buy |
63,062
+39,762
| +171% | +$6.74M | 0.03% | 381 |
|
2021
Q3 | $4.4M | Sell |
23,300
-1,100
| -5% | -$208K | 0.01% | 537 |
|
2021
Q2 | $4.14M | Sell |
24,400
-200
| -0.8% | -$33.9K | 0.01% | 567 |
|
2021
Q1 | $3.47M | Sell |
24,600
-8,100
| -25% | -$1.14M | 0.01% | 579 |
|
2020
Q4 | $4.25M | Buy |
32,700
+400
| +1% | +$52K | 0.01% | 538 |
|
2020
Q3 | $4.7M | Buy |
32,300
+2,500
| +8% | +$364K | 0.02% | 439 |
|
2020
Q2 | $4.41M | Buy |
29,800
+2,100
| +8% | +$311K | 0.02% | 452 |
|
2020
Q1 | $3.02M | Buy |
+27,700
| New | +$3.02M | 0.01% | 485 |
|
2018
Q3 | – | Sell |
-9,302
| Closed | -$916K | – | 692 |
|
2018
Q2 | $916K | Hold |
9,302
| – | – | ﹤0.01% | 649 |
|
2018
Q1 | $1.11M | Buy |
+9,302
| New | +$1.11M | 0.01% | 599 |
|